Dr Reddys beats Aurobindo Pharma to become second biggest drug maker in India: Report Farhat Nasim22 Nov 2022 6:36 PM ISTNew Delhi: A change in the ranking of India's USD 50 billion pharma industry in over 7 years was witnessed as Hyderabad-based Dr Reddy's...
Lupin CSR arm, Rajasthan Govt join hands to strengthen Healthcare system Ruchika Sharma21 Nov 2022 1:00 PM ISTJaipur: Lupin Human Welfare and Research Foundation (LHWRF), the Corporate Social Responsibility (CSR) arm of Lupin Limited, announced today that it...
Lupin reports net profit of Rs 130 crore in Q2 Ruchika Sharma11 Nov 2022 3:30 PM ISTNew Delhi: Drug maker Lupin on Wednesday said its consolidated net profit stood at Rs 130 crore for the second quarter ended September 30, 2022.The...
Lupin gets USFDA nod for generic equivalent of Oracea Capsules Ruchika Sharma8 Nov 2022 5:30 PM ISTORACEA is a tetracycline class drug indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients.
Lupin bags USFDA nod for generic equivalent of Slynd Tablets Ruchika Sharma4 Nov 2022 1:28 PM ISTMumbai: Global pharma major Lupin Limited today announced that the company has received tentative approval from the United States Food and Drug...
Lupin Tarapur facility gets USFDA warning letter Ruchika Sharma3 Nov 2022 1:30 PM IST"This warning letter summarises significant deviations from current good manufacturing practice (CGMP) for active pharmaceutical ingredients (API),"...
USFDA issues 5 observations for Lupin Nagpur facility Ruchika Sharma31 Oct 2022 11:32 AM ISTMumbai: Lupin has recently announced that the US Food and Drug Administration has concluded a Pre-Approval Inspection (PAI) with five observations at...
Lupin Ranibizumab intravitreal injection gets CDSCO Panel nod for Phase IV study Dr. Divya Colin25 Oct 2022 10:45 AM ISTNew Delhi: Pharmaceuticals major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin unveils Paliperidone ER Tablets in US Ruchika Sharma21 Oct 2022 11:26 AM ISTSchizophrenia is frequently associated with significant distress and impairment in personal, family, social, educational, occupational, and other...
Lupin to acquire two inhalation medicines from Sunovion Pharma for over Rs 623 crore Ruchika Sharma20 Oct 2022 12:15 PM ISTBrovana is indicated for long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including...
Lupin gets 17 USFDA observations for Pune facility Ruchika Sharma20 Oct 2022 11:20 AM IST"The Company does not believe that the 483 letter will have an impact on the existing revenues from operations of this facility," Lupin stated.
Lupin Gets CDSCO Panel nod To study LUBT017 Biosimilar to Eylea Dr. Divya Colin15 Oct 2022 6:00 PM ISTNew Delhi: Directing to appoint an independent data safety monitoring committee, the Subject Expert Committee (SEC) functional under Central Drug...
